- Home
- BHF vs XENE Comparison
BHF vs XENE Comparison
Compare BHF & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BHF | XENE |
|---|---|---|
| Founded | 2016 | 1996 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Life Insurance | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.4B |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | BHF | XENE |
|---|---|---|
| Price | $64.91 | $44.14 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 9 | 11 |
| Target Price | ★ $58.88 | $53.91 |
| AVG Volume (30 Days) | ★ 868.1K | 821.7K |
| Earning Date | 02-10-2026 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 14.74 | N/A |
| Revenue | ★ $7,830,000,000.00 | $7,500,000.00 |
| Revenue This Year | $40.59 | N/A |
| Revenue Next Year | $2.84 | N/A |
| P/E Ratio | $4.40 | ★ N/A |
| Revenue Growth | ★ 48.75 | N/A |
| 52 Week Low | $42.07 | $26.74 |
| 52 Week High | $66.33 | $46.60 |
Technical Indicators
Market Signals| Indicator | BHF | XENE |
|---|---|---|
| Relative Strength Index (RSI) | 61.12 | 58.41 |
| Support Level | $65.28 | $42.44 |
| Resistance Level | $65.51 | $44.57 |
| Average True Range (ATR) | 0.26 | 1.33 |
| MACD | -0.55 | -0.16 |
| Stochastic Oscillator | 36.48 | 40.64 |
Price Performance
Historical ComparisonAbout BHF Brighthouse Financial Inc.
Brighthouse Financial Inc is a United States-based provider of annuity products and life insurance through independent distribution channels and marketing arrangements with distribution partners. Its segments are Annuities, Life, Run-off and Corporate and Other. It derives a majority of the revenue from the Annuities segment which includes variable, fixed, index-linked, and income annuities. The life segment includes variable, term, universal, and whole life policies.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.